Cargando…
Cardiolipin, the Mitochondrial Signature Lipid: Implication in Cancer
Cardiolipins (CLs) are specific phospholipids of the mitochondria composing about 20% of the inner mitochondria membrane (IMM) phospholipid mass. Dysregulation of CL metabolism has been observed in several types of cancer. In most cases, the evidence for a role for CL in cancer is merely correlative...
Autores principales: | Ahmadpour, Seyedeh Tayebeh, Mahéo, Karine, Servais, Stéphane, Brisson, Lucie, Dumas, Jean-François |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662448/ https://www.ncbi.nlm.nih.gov/pubmed/33126604 http://dx.doi.org/10.3390/ijms21218031 |
Ejemplares similares
-
Doxorubicin-Induced Autophagolysosome Formation Is Partly Prevented by Mitochondrial ROS Elimination in DOX-Resistant Breast Cancer Cells
por: Ahmadpour, Seyedeh Tayebeh, et al.
Publicado: (2021) -
Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA
por: Ahmadpour, Seyedeh Tayebeh, et al.
Publicado: (2023) -
Cardiolipin, Perhydroxyl Radicals, and Lipid Peroxidation in Mitochondrial Dysfunctions and Aging
por: Panov, Alexander V., et al.
Publicado: (2020) -
Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?
por: Dolly, Adeline, et al.
Publicado: (2020) -
Lipids in Mitochondrial Macroautophagy: Phase Behavior of Bilayers Containing Cardiolipin and Ceramide
por: Varela, Yaiza R., et al.
Publicado: (2023)